| Literature DB >> 19129445 |
Marcela F Pasetti1, Karina Ramirez, Aldo Resendiz-Albor, Jeffrey Ulmer, Eileen M Barry, Myron M Levine.
Abstract
Measles remains an important cause of pediatric morbidity and mortality in developing countries, especially among infants who are too young to receive the current licensed live attenuated measles vaccine. We developed two Sindbis virus DNA vaccines encoding the measles virus hemagglutinin (pMSIN-H) and fusion proteins (pMSINH-FdU) and examined their immunogenicities and protective efficacies when administered alone or followed by the live measles virus vaccine in cotton rats. Neutralizing antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and gamma interferon-secreting T cells developed after priming and increased after boosting. pMSIN-H priming conferred 100% protection against pulmonary measles, whereas pMSINH-FdU protected only in conjunction with the live measles virus vaccine boost.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19129445 PMCID: PMC2648279 DOI: 10.1128/JVI.02191-08
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103